UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date of earliest event reported) November
6, 2006
Advanced
Biotherapy, Inc.
(Exact
name of registrant as specified in its chapter)
|
Delaware
|
|
0-26323
|
|
51-0402415
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer Identification
No.)
|
| |
|
|
|
|
| |
|
|
|
|
|
141
West Jackson Boulevard, Suite
2182
Chicago,
Illinois
|
|
|
|
60604
|
|
(Address
of principal executive
offices)
|
|
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (312)
427-1912
Item
5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
(b) As
of
November 6, 2006, Edmond F. Buccellato, Lawrence Loomis and Simon Skurkovich,
M.D. resigned as directors of the Company. Each of them has been appointed
to
the Company’s Advisory Board.
(c) As
of
November 6, 2006, the Board of Directors (the “Board”) appointed Christopher W.
Capps, John R. Capps, Matt Gooch and David Valentine to the Board of Directors.
Christopher
W. Capps has served as President and Chief Executive Officer of Advanced
Biotherapy, Inc. (the “Company”) since August 2006. Since
September 2005, Mr. Capps (24) has also served as President and CEO of KVG
Partners, a private equity firm. Mr. Capps received his B.A. in history from
Southern Methodist University. Mr. Capps has been appointed to the Company’s
Executive Committee of the Board of Directors.
John
R.
Capps has been the President and CEO of Plaza Motor Company, for 25 years.
Plaza
Motor Company is part of the Asbury Automotive Group, which is a publicly
owned
Group on the New York Stock Exchange. Mr. Capps has worked in the automotive
industry since his graduation from Stanford University in 1972 with a B.A.
in
English. Mr. Capps has been appointed to the Compensation, Nominating and
Executive Committees of the Board of Directors. He is the father of Christopher
W. Capps, President and Chief Executive Officer of the Company.
Matt
Gooch joined William Blair & Company in 1997 and currently coordinates the
firm’s special situations and restructuring activities. Mr. Gooch is a CFA
charter holder and a graduate of Emory University (B.A.) and University of
Chicago (M.B.A.), having earned high honors from both institutions. Mr. Gooch
has been appointed to the Audit, Nominating and Executive Committees of the
Company’s Board of Directors.
David
Valentine has been President and Managing Partner of Broadreach Financial
Group
LLC, a financial advisory firm, and Managing Partner of the Broadreach Steward
Fund LLC, a private equity fund, since 2006. Previously, Mr. Valentine was
a
portfolio manager at Magnetar Capital LLC, a multi-billion dollar hedge fund
based in Evanston, Illinois. Mr. Valentine serves on the Boards of Directors
of
Ambiron Trustwave LLC and Lime Energy, Inc., where he also serves on the
Audit
Committees. He also serves on the Board of Directors of Inovomed, Inc. and
Friends of the Global Fight against AIDS, Malaria and Tuberculosis. He is
a 1993
graduate of Washington & Lee University. Mr. Valentine has been appointed to
the Audit, Compensation and Executive Committees of the Company’s Board of
Directors. Mr. Valentine is the son-in-law of Richard P. Kiphart, Chairman
of
the Board of Directors of the Company.
FORWARD-LOOKING
STATEMENTS
This
Form
8-K may contain forward-looking statements. These statements are based upon
the
Company’s beliefs and expectations. They are not guarantees of future
performance and involve certain risks, uncertainties and assumptions that
are
difficult to predict. See the Company’s public filings for more detailed
information on the risks and uncertainties that may affect the Company and
the
results or expectations expressed in our forward-looking statements. We assume
no obligation to update publicly any forward-looking statements, whether
as a
result of new information, future events or otherwise.
Item
9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(c)
Exhibits.
Designation Description
of Exhibit
None.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
ADVANCED
BIOTHERAPY, INC.
|
|
|
|
| Date: November
8, 2006 |
By: |
/s/ Christopher
W. Capps |
| |
Christopher
W. Capps, President
and
Chief Executive
Officer
|
INDEX
TO
EXHIBITS
None